Aridis Pharmaceuticals, Inc. (ARDS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

1.8600

+0.0300

(+1.64%)

At close: 04:00PM EDT

Loading interactive chart...

Zacks
Aridis Pharmaceuticals (ARDS) Reports Q2 Loss, Misses Revenue Estimates
Aridis Pharmaceuticals (ARDS) delivered earnings and revenue surprises of -650% and 97.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Pfizer (PFE) Seeks FDA Nod for Its Oral Antiviral COVID Pill
Pfizer (PFE) submits NDA to the FDA seeking approval for using its oral antiviral COVID pill in vaccinated and unvaccinated patients at a high risk of developing severe COVID-19 complications.
Zacks
Here's Why Aridis Pharmaceuticals (ARDS) Looks Ripe for Bottom Fishing
Aridis Pharmaceuticals (ARDS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.